Risk of urothelial cancer death among people using antihypertensive drugs-a cohort study from Finland.
Conclusions: This large population-based cohort suggests decreased risk of BCa death among ATR-blocker and calcium-channel blocker users. The risk association among ATR-blockers and calcium-channel blockers was dose-dependent suggesting a causal explanation. Similar risk associations are not observed for other anti-HT drug users, which may suggest a direct effect of ATR blocker or calcium-channel blocker use. Further studies are needed to elucidate the potential anticancer mechanism.
PMID: 31250699 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Urology - Category: Urology & Nephrology Tags: Scand J Urol Source Type: research
More News: Bladder Cancer | Calcium | Cancer | Cancer & Oncology | Carcinoma | Finland Health | Hypertension | PET Scan | Study | Urology & Nephrology